Friday, May 1, 2020

MPR

NEW DRUG PRODUCT: TALICIA

FEATURED
Find out more about Talicia including dosing and important safety information with our slideshow, complete drug monograph, and downloadable PDF.

DRUGS IN THE PIPELINE

Trial Evaluating Ruxolitinib for COVID-19 Associated Cytokine Storm Initiated

FDA to Review Data on Shorter Infusion Time for MS Drug Ocrevus

Investigational Triple Antibody Cocktail Under Review for Ebola Virus Infection

Novel Pyruvate Kinase Activator Gets Orphan Drug Status for Sickle Cell Disease

Telitacicept Fast-Tracked for Systemic Lupus Erythematosus

MPR The right dose
of information.

eMPR.com

Featured Content

Exploring Real-World Data Use Around the World

Conducting real-world data analyses to generate real-world evidence is becoming increasingly common. What are the applications and limitations of this practice? Find Out Now.

CME/CE Spotlight

A Multidisciplinary Approach to the Management of Psoriatic Arthritis

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists


CLICK HERE FOR A FULL LIST OF COURSES
CE/CME Powered By myCME

No comments:

Post a Comment